Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.

Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER.

Sci Rep. 2019 Jun 14;9(1):8721. doi: 10.1038/s41598-019-44365-2.

PMID:
31197238
2.

First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.

Funes CJ, Mace RA, Macklin EA, Plotkin SR, Jordan JT, Vranceanu AM.

J Neurooncol. 2019 May 2. doi: 10.1007/s11060-019-03182-3. [Epub ahead of print]

PMID:
31049826
3.

Influenza in Latin America: A report from the Global Influenza Initiative (GII).

Gentile A, Paget J, Bellei N, Torres JP, Vazquez C, Laguna-Torres VA, Plotkin S; GII.

Vaccine. 2019 May 6;37(20):2670-2678. doi: 10.1016/j.vaccine.2019.03.081. Epub 2019 Apr 8. Review.

PMID:
30975568
4.

First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.

Rauen KA, Alsaegh A, Ben-Shachar S, Berman Y, Blakeley J, Cordeiro I, Elgersma Y, Evans DG, Fisher MJ, Frayling IM, George J, Huson SM, Kerr B, Khire U, Korf B, Legius E, Messiaen L, van Minkelen R, Nampoothiri S, Ngeow J, Parada LF, Phadke S, Pillai A, Plotkin SR, Puri R, Raji A, Ramesh V, Ratner N, Shankar SP, Sharda S, Tambe A, Vikkula M, Widemann BC, Wolkenstein P, Upadhyaya M.

Am J Med Genet A. 2019 Jun;179(6):1091-1097. doi: 10.1002/ajmg.a.61125. Epub 2019 Mar 25.

PMID:
30908877
5.

From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.

Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS.

Am J Med Genet A. 2019 Jun;179(6):1098-1106. doi: 10.1002/ajmg.a.61112. Epub 2019 Mar 25.

PMID:
30908866
6.

How to Prepare for Expert Testimony on the Safety of Vaccination.

Plotkin SA.

Pediatrics. 2019 Apr;143(4). pii: e20183578. doi: 10.1542/peds.2018-3578. Epub 2019 Mar 6. No abstract available.

PMID:
30842258
7.

Chikungunya Virus: A Back-Breaking Problem.

Plotkin SA.

J Pediatric Infect Dis Soc. 2019 May 11;8(2):95-96. doi: 10.1093/jpids/piz012. No abstract available.

PMID:
30840767
8.

Dengue Vaccine, A Double-Edged Sword.

Plotkin SA.

J Pediatric Infect Dis Soc. 2019 Jan 18. doi: 10.1093/jpids/piy140. [Epub ahead of print] No abstract available.

PMID:
30657941
9.

A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.

Chen J, Landegger LD, Sun Y, Ren J, Maimon N, Wu L, Ng MR, Chen JW, Zhang N, Zhao Y, Gao X, Fujita T, Roberge S, Huang P, Jain RK, Plotkin SR, Stankovic KM, Xu L.

Nat Protoc. 2019 Feb;14(2):541-555. doi: 10.1038/s41596-018-0105-7.

PMID:
30617350
10.

The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit.

Meissner HC, Nair N, Plotkin SA.

JAMA. 2019 Jan 29;321(4):343-344. doi: 10.1001/jama.2018.20421. No abstract available.

PMID:
30608524
11.

The changing epidemiology of mumps in a high vaccination era.

Marshall HS, Plotkin S.

Lancet Infect Dis. 2019 Feb;19(2):118-119. doi: 10.1016/S1473-3099(18)30541-3. Epub 2018 Dec 14. No abstract available. Erratum in: Lancet Infect Dis. 2019 Feb;19(2):e39.

PMID:
30558996
12.

CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding.

Farrawell NE, Yerbury MR, Plotkin SS, McAlary L, Yerbury JJ.

ACS Chem Neurosci. 2019 Mar 20;10(3):1555-1564. doi: 10.1021/acschemneuro.8b00527. Epub 2018 Dec 7.

PMID:
30462490
13.

Ten yearly yellow fever booster vaccinations may still be justified.

Plotkin SA.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay130. No abstract available.

PMID:
30462249
14.

Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Ina Ly K, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER.

Sci Rep. 2018 Nov 20;8(1):17062. doi: 10.1038/s41598-018-34820-x. Erratum in: Sci Rep. 2019 Jun 14;9(1):8721.

15.

Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines.

Plotkin SA, Offit PA, Reiss D.

Pediatr Infect Dis J. 2018 Dec;37(12):e353. doi: 10.1097/INF.0000000000002210. No abstract available.

PMID:
30408015
16.

Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.

Vranceanu AM, Zale EL, Funes CJ, Macklin EA, McCurley J, Park ER, Jordan JT, Lin A, Plotkin SR.

JMIR Res Protoc. 2018 Oct 23;7(10):e11008. doi: 10.2196/11008.

17.

Prediction of Misfolding-Specific Epitopes in SOD1 Using Collective Coordinates.

Peng X, Cashman NR, Plotkin SS.

J Phys Chem B. 2018 Dec 13;122(49):11662-11676. doi: 10.1021/acs.jpcb.8b07680. Epub 2018 Nov 5.

PMID:
30351123
18.

Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.

Forsyth KD, Tan T, von König CW, Heininger U, Chitkara AJ, Plotkin S.

Vaccine. 2018 Nov 19;36(48):7270-7275. doi: 10.1016/j.vaccine.2018.10.028. Epub 2018 Oct 15. Review.

19.

pH dependent membrane binding of the Solanum tuberosum plant specific insert: An in silico study.

Dupuis JH, Yu H, Habibi M, Peng X, Plotkin SS, Wang S, Song C, Yada RY.

Biochim Biophys Acta Biomembr. 2018 Dec;1860(12):2608-2618. doi: 10.1016/j.bbamem.2018.10.001. Epub 2018 Oct 3.

PMID:
30291921
20.

Lemons and Lyme.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):267-269. doi: 10.1093/jpids/piy083. No abstract available.

PMID:
30212842
21.

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.

Merker VL, Dai A, Radtke HB, Knight P, Jordan JT, Plotkin SR.

BMC Health Serv Res. 2018 Aug 29;18(1):668. doi: 10.1186/s12913-018-3471-5.

22.

Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Plotkin SA.

J Clin Invest. 2018 Aug 31;128(9):3742-3744. doi: 10.1172/JCI122726. Epub 2018 Aug 6.

23.

Benign Intracranial Tumors.

Jordan JT, Plotkin SR.

Neurol Clin. 2018 Aug;36(3):501-516. doi: 10.1016/j.ncl.2018.04.007. Review.

PMID:
30072068
24.

Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection".

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Jul 17;92(15). pii: e00771-18. doi: 10.1128/JVI.00771-18. Print 2018 Aug 1. No abstract available.

25.

Considerations for development of therapies for cutaneous neurofibroma.

Verma SK, Riccardi VM, Plotkin SR, Weinberg H, Anderson RR, Blakeley JO, Jarnagin K, Lee J.

Neurology. 2018 Jul 10;91(2 Supplement 1):S21-S30. doi: 10.1212/WNL.0000000000005791.

PMID:
29987132
26.

Cutaneous neurofibromas: Current clinical and pathologic issues.

Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A, Carroll SL, Verma SK, Mautner V, Upadhyaya M, Stemmer-Rachamimov A.

Neurology. 2018 Jul 10;91(2 Supplement 1):S5-S13. doi: 10.1212/WNL.0000000000005792.

PMID:
29987130
27.

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.

Angus SP, Oblinger JL, Stuhlmiller TJ, DeSouza PA, Beauchamp RL, Witt L, Chen X, Jordan JT, Gilbert TSK, Stemmer-Rachamimov A, Gusella JF, Plotkin SR, Haggarty SJ, Chang LS, Johnson GL, Ramesh V; Children’s Tumor Foundation Synodos for NF2 Consortium .

Neuro Oncol. 2018 Aug 2;20(9):1185-1196. doi: 10.1093/neuonc/noy046.

PMID:
29982664
28.

The Influenza Vaccine Mess.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):178-180. doi: 10.1093/jpids/piy057. No abstract available.

PMID:
29982613
29.

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.

Synodos for NF2 Consortium, Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN.

PLoS One. 2018 Jun 13;13(6):e0197350. doi: 10.1371/journal.pone.0197350. eCollection 2018.

30.

Portait of an ISV fellow.

Plotkin SA.

Hum Vaccin Immunother. 2018;14(8):1836-1839. doi: 10.1080/21645515.2018.1480199. Epub 2018 Jun 22. No abstract available.

31.

Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.

Brastianos PK, Nayyar N, Rosebrock D, Leshchiner I, Gill CM, Livitz D, Bertalan MS, D'Andrea M, Hoang K, Aquilanti E, Chukwueke UN, Kaneb A, Chi A, Plotkin S, Gerstner ER, Frosch MP, Suva ML, Cahill DP, Getz G, Batchelor TT.

NPJ Precis Oncol. 2017 Sep 18;1(1):33. doi: 10.1038/s41698-017-0035-9. eCollection 2017.

32.

Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study," by Mussi-Pinhata et al.

Plotkin SA.

J Infect Dis. 2018 Sep 8;218(8):1188-1190. doi: 10.1093/infdis/jiy322. No abstract available.

PMID:
29868893
33.

Mumps: A Pain in the Neck.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 May 15;7(2):91-92. doi: 10.1093/jpids/piy038. No abstract available.

PMID:
29718326
34.

The Added Value of the Lateral Chest Radiograph for Diagnosing Community Acquired Pneumonia in the Pediatric Emergency Department.

Soudack M, Plotkin S, Ben-Shlush A, Raviv-Zilka L, Jacobson JM, Benacon M, Augarten A.

Isr Med Assoc J. 2018 Jan;20(1):5-8.

35.

Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.

Huang V, Bergner AL, Halpin C, Merker VL, Sheridan MR, Widemann BC, Blakeley JO, Plotkin SR.

Otol Neurotol. 2018 Jun;39(5):632-638. doi: 10.1097/MAO.0000000000001781.

PMID:
29649040
36.

Vaccination against the human cytomegalovirus.

Plotkin SA, Boppana SB.

Vaccine. 2018 Apr 2. pii: S0264-410X(18)30288-3. doi: 10.1016/j.vaccine.2018.02.089. [Epub ahead of print]

37.

A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.

Silverman JM, Gibbs E, Peng X, Martens KM, Balducci C, Wang J, Yousefi M, Cowan CM, Lamour G, Louadi S, Ban Y, Robert J, Stukas S, Forloni G, Hsiung GR, Plotkin SS, Wellington CL, Cashman NR.

ACS Chem Neurosci. 2018 Jul 18;9(7):1591-1606. doi: 10.1021/acschemneuro.7b00469. Epub 2018 Apr 16.

PMID:
29614860
38.

Neurofibromatosis and Schwannomatosis.

Plotkin SR, Wick A.

Semin Neurol. 2018 Feb;38(1):73-85. doi: 10.1055/s-0038-1627471. Epub 2018 Mar 16. Review.

PMID:
29548054
39.

Schwannomatosis.

Dhamija R, Plotkin S, Asthagiri A, Messiaen L, Babovic-Vuksanovic D.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2018 Mar 8.

40.

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.

Zhao Y, Liu P, Zhang N, Chen J, Landegger LD, Wu L, Zhao F, Zhao Y, Zhang Y, Zhang J, Fujita T, Stemmer-Rachamimov A, Ferraro GB, Liu H, Muzikansky A, Plotkin SR, Stankovic KM, Jain RK, Xu L.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2077-E2084. doi: 10.1073/pnas.1719966115. Epub 2018 Feb 9.

41.

Soft Vibrational Modes Predict Breaking Events during Force-Induced Protein Unfolding.

Habibi M, Plotkin SS, Rottler J.

Biophys J. 2018 Feb 6;114(3):562-569. doi: 10.1016/j.bpj.2017.11.3781.

42.

Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly.

Baltimore RS, Nimkin K, Sparger KA, Pierce VM, Plotkin SA.

N Engl J Med. 2018 Feb 8;378(6):564-572. doi: 10.1056/NEJMcpc1706110. No abstract available.

PMID:
29414276
43.

Pain correlates with germline mutation in schwannomatosis.

Jordan JT, Smith MJ, Walker JA, Erdin S, Talkowski ME, Merker VL, Ramesh V, Cai W, Harris GJ, Bredella MA, Seijo M, Suuberg A, Gusella JF, Plotkin SR.

Medicine (Baltimore). 2018 Feb;97(5):e9717. doi: 10.1097/MD.0000000000009717.

44.

Vaccine mandates in France will save lives.

Plotkin SA, Offit P, Bégué P.

Science. 2018 Jan 19;359(6373):283-284. doi: 10.1126/science.aar4422. No abstract available.

PMID:
29348229
45.

Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Mar 14;92(7). pii: e00030-18. doi: 10.1128/JVI.00030-18. Print 2018 Apr 1. Review.

46.

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, Hsiao MC, Chen Z, Balasubramanian M, Barnett CP, Becker TA, Ben-Shachar S, Bertola DR, Blakeley JO, Burkitt-Wright EMM, Callaway A, Crenshaw M, Cunha KS, Cunningham M, D'Agostino MD, Dahan K, De Luca A, Destrée A, Dhamija R, Eoli M, Evans DGR, Galvin-Parton P, George-Abraham JK, Gripp KW, Guevara-Campos J, Hanchard NA, Hernández-Chico C, Immken L, Janssens S, Jones KJ, Keena BA, Kochhar A, Liebelt J, Martir-Negron A, Mahoney MJ, Maystadt I, McDougall C, McEntagart M, Mendelsohn N, Miller DT, Mortier G, Morton J, Pappas J, Plotkin SR, Pond D, Rosenbaum K, Rubin K, Russell L, Rutledge LS, Saletti V, Schonberg R, Schreiber A, Seidel M, Siqveland E, Stockton DW, Trevisson E, Ullrich NJ, Upadhyaya M, van Minkelen R, Verhelst H, Wallace MR, Yap YS, Zackai E, Zonana J, Zurcher V, Claes K, Martin Y, Korf BR, Legius E, Messiaen LM.

Am J Hum Genet. 2018 Jan 4;102(1):69-87. doi: 10.1016/j.ajhg.2017.12.001. Epub 2017 Dec 28.

47.

Third Dose of MMR Vaccine for Mumps Control.

Plotkin SA.

N Engl J Med. 2017 Dec 14;377(24):2403. doi: 10.1056/NEJMc1714219. No abstract available.

PMID:
29236638
48.

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.

Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT.

NPJ Precis Oncol. 2017;1. pii: 20. doi: 10.1038/s41698-017-0020-3. Epub 2017 Jun 12.

49.

Vaccines We Need But Don't Have.

Plotkin SA.

Viral Immunol. 2018 Mar;31(2):114-116. doi: 10.1089/vim.2017.0126. Epub 2017 Nov 13. Review.

PMID:
29131713
50.

Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.

Merker VL, McDannold S, Riklin E, Talaei-Khoei M, Sheridan MR, Jordan JT, Plotkin SR, Vranceanu AM.

J Neurooncol. 2018 Jan;136(2):335-342. doi: 10.1007/s11060-017-2657-8. Epub 2017 Nov 8.

PMID:
29119424

Supplemental Content

Loading ...
Support Center